ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 175 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $276,000 | -40.4% | 2,422 | -27.6% | 0.09% | -47.0% |
Q4 2020 | $463,000 | -3.3% | 3,344 | -42.7% | 0.17% | -17.4% |
Q3 2020 | $479,000 | +1128.2% | 5,832 | +556.8% | 0.20% | +168.0% |
Q1 2020 | $39,000 | +178.6% | 888 | +178.4% | 0.08% | +15.4% |
Q4 2018 | $14,000 | – | 319 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $4,658,000 | 2.63% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,364,434 | $84,745,000 | 1.21% |
CAPITAL INTERNATIONAL LTD /CA/ | 259,700 | $16,130,000 | 1.07% |
Aureus Asset Management, LLC | 65,670 | $4,079,000 | 0.69% |
Capital International Sarl | 124,320 | $7,722,000 | 0.67% |
CAPITAL GUARDIAN TRUST CO | 512,430 | $31,827,000 | 0.58% |
ROCKEFELLER FINANCIAL SERVICES INC | 408,379 | $25,365,000 | 0.50% |
Rock Springs Capital Management LP | 160,500 | $9,969,000 | 0.50% |
Hood River Capital Management LLC | 112,296 | $6,975,000 | 0.48% |
Capital International, Inc./CA/ | 52,700 | $3,273,000 | 0.47% |